Crystal structure, catalytic mechanism, and mitogenic properties of Trypanosoma cruzi proline racemase A Buschiazzo, M Goytia, F Schaeffer, W Degrave, W Shepard, C Grégoire, ... Proceedings of the National Academy of Sciences 103 (6), 1705-1710, 2006 | 114 | 2006 |
Copper (II)-bis (thiosemicarbazonato) complexes as antibacterial agents: insights into their mode of action and potential as therapeutics KY Djoko, MM Goytia, PS Donnelly, MA Schembri, WM Shafer, ... Antimicrobial agents and chemotherapy 59 (10), 6444-6453, 2015 | 80 | 2015 |
Trypanosoma cruzi proline racemases are involved in parasite differentiation and infectivity N Chamond, M Goytia, N Coatnoan, JC Barale, A Cosson, WM Degrave, ... Molecular microbiology 58 (1), 46-60, 2005 | 74 | 2005 |
Commensal Neisseria kill Neisseria gonorrhoeae through a DNA-dependent mechanism WJ Kim, D Higashi, M Goytia, MA Rendón, M Pilligua-Lucas, ... Cell host & microbe 26 (2), 228-239. e8, 2019 | 62 | 2019 |
Polyamines Can Increase Resistance of Neisseria gonorrhoeae to Mediators of the Innate Human Host Defense M Goytia, WM Shafer Infection and immunity 78 (7), 3187-3195, 2010 | 50 | 2010 |
Spermine impairs biofilm formation by Neisseria gonorrhoeae M Goytia, VL Dhulipala, WM Shafer FEMS microbiology letters 343 (1), 64-69, 2013 | 46 | 2013 |
Molecular and structural discrimination of proline racemase and hydroxyproline-2-epimerase from nosocomial and bacterial pathogens M Goytia, N Chamond, A Cosson, N Coatnoan, D Hermant, A Berneman, ... PLoS One 2 (9), e885, 2007 | 46 | 2007 |
Overproduction of the MtrCDE efflux pump in Neisseria gonorrhoeae produces unexpected changes in cellular transcription patterns EA Ohneck, M Goytia, CE Rouquette-Loughlin, SJ Joseph, TD Read, ... Antimicrobial Agents and Chemotherapy 59 (1), 724-726, 2015 | 16 | 2015 |
Antimicrobial Resistance Profiles of Human Commensal Neisseria Species M Goytia, ST Thompson, SVL Jordan, KA King Antibiotics 10 (5), 538, 2021 | 14 | 2021 |
Mechanisms and significance of bacterial resistance to human cationic antimicrobial peptides M Goytia, JL Kandler, WM Shafer Antimicrobial peptides and innate immunity, 219-254, 2012 | 13 | 2012 |
Canary in the Coal Mine: How Resistance Surveillance in Commensals Could Help Curb the Spread of AMR in Pathogenic Neisseria M Goytia, CB Wadsworth Mbio 13 (5), e01991-22, 2022 | 10 | 2022 |
Characterization of a spermine/spermidine transport system reveals a novel DNA sequence duplication in Neisseria gonorrhoeae M Goytia, L Hawel III, VL Dhulipala, SJ Joseph, TD Read, WM Shafer FEMS Microbiology Letters 362 (16), fnv125, 2015 | 8 | 2015 |
COMPOSITIONS AND METHODS FOR TREATING GONORRHEA WJ KIM, MA RENDÓN-ESPINOSA, MY SO, M GOYTIA, A JERSE, ... WO Patent WO/2016/036,839, 2016 | 6 | 2016 |
Function and Regulation of Neisseria gonorrhoeae Efflux Pumps YM Zalucki, AD Mercante, JM Cloward, EA Ohneck, JL Kandler, M Goytia, ... Microbial Efflux Pumps: Current Research., Chapter 10, 2014 | 6 | 2014 |
Identification and characterization of novel proline racemases and hydroxyproline-2-epimerases, uses thereof, and methods of identifying proline racemases and hydroxyproline-2 … P Minoprio, M Goytia, N Chamond US Patent App. 11/896,596, 2008 | 1 | 2008 |
Compositions and methods for treating bacterial disease WJ Kim, MA Rendón-Espinosa, MY So, M Goytia, A Jerse, D Higashi US Patent 10,900,043, 2021 | | 2021 |
Copper (II)-Bis (Thiosemicarbazonato) Complexes as Antibacterial Agents: Insights into Their Mode of Action and Potential as KY Djoko, MM Goytia, PS Donnelly, MA Schembri, WM Shafer, ... | | 2015 |
Molecular and Structural Discrimination of Proline Racemase and M Goytia, N Chamond, A Cosson, N Coatnoan, D Hermant | | 2007 |
Les racémases et épimérases d'acides aminés: l'exemple de la TcPRAC comme cible pour le développement d'une thérapie contre l'infection par Trypanosoma cruzi M Goytia Paris 6, 2007 | | 2007 |
Microbial Efflux Pumps WH Zheng, E Wang, JD Nguyen, MH Saier Jr, BF Luisi, F Long, HT Lei, ... | | |